ZNTL

Zentalis Pharmaceuticals Stock Analysis

AI Rating

Good
  • Quality2/10
  • Growth↑ 7/10
  • Value↑ 5/10
Zentalis Pharmaceuticals sales and earnings growth
ZNTL Growth
Good
  • Revenue Y/Y↓ -200.00%
  • EPS Y/Y↑ 16.87%
  • FCF Y/Y↑ 22.46%
Zentalis Pharmaceuticals gross and profit margin trends
ZNTL Profitability
Fair
  • Gross margin ↑ 100.00%
  • EPS margin↑ 368.10%
  • ROIC 5Y↓ -52.84%
Zentalis Pharmaceuticals net debt vs free cash flow
ZNTL Risk
Great
  • Debt / Equity↓ 0.1
  • Debt / FCF↓ 0.0
  • Interest coverage↑ 999.0

Zentalis Pharmaceuticals stock volatility is higher than the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗